Top Stocks in the Economic Recovery The economic climate in 2020 has been… unexpected, to say the least. The arrival and subsequent devastation wrought by the novel coronavirus has sent markets into a volatile ride that no one could have foreseen. But all that is behind us now. What... Read more
MedPharm, a Colorado-based cannabis research and formulation development company, has received a Medical Marijuana Research and Development License from the City of Denver, the last piece in the licensing puzzle for the company’s study on how cannabis-based medication might impact Alzheimer’s disease and other forms of dementia. MedPharm received... Read more
MedPharm, a Colorado-based cannabis research and formulation development company, has received a Medical Marijuana Research and Development License from the City of Denver, the last piece in the licensing puzzle for the company’s study on how cannabis-based medication might impact Alzheimer’s disease and other forms of dementia. MedPharm received... Read more
MedPharm, a Colorado-based cannabis research and formulation development company, has received a Medical Marijuana Research and Development License from the City of Denver, the last piece in the licensing puzzle for the company’s study on how cannabis-based medication might impact Alzheimer’s disease and other forms of dementia. MedPharm received... Read more
EDMONTON, Alberta, June 23, 2020 /CNW/ -PRESS RELEASE- Aurora Cannabis Inc., one of Canada’s largest cannabis producers, provided on June 23 a progress update on its Business Transformation Plan that was previously announced Feb. 6, 2020. “Across our organization we continue to take decisive action and execute on our... Read more
EDMONTON, Alberta, June 23, 2020 /CNW/ -PRESS RELEASE- Aurora Cannabis Inc., one of Canada’s largest cannabis producers, provided on June 23 a progress update on its Business Transformation Plan that was previously announced Feb. 6, 2020. “Across our organization we continue to take decisive action and execute on our... Read more
The United Kingdom has down-scheduled Epidyolex to the lowest level of control for drugs, greatly easing restrictions on the cannabidiol medicine and reducing red tape for companies that supply it. The new classification came into force Wednesday. “This will reduce administrative processes for companies wanting to supply Epidyolex to... Read more
Last week, the National Credit Union Administration (NCUA) issued new guidance (“Guidance”) for federally-chartered credit unions serving the hemp industry. All of us at Harris Bricken were excited to see the Guidance released: NCUA retained us last fall to advise the government on this project, and we have always represented credit union clients as to […]
The results of a recent study show that patients with irritable bowel syndrome (IBS) who have a history of cannabis use spent less time in the hospital and had lower inpatient health care utilization and associated costs. A report on the research, “Association between cannabis use and healthcare utilization... Read more
Pregnant cannabis users deal with stigma and stress over the possibility of losing custody, all because they medicate with a plant that is still illegal on a federal level. Despite the legal statuses of cannabis in each state, the Federal classification supersedes in a situation involving the local child... Read more
